Where are children ages 5-17 years receiving their COVID-19 vaccinations? Variations over time and by sociodemographic characteristics, United States

被引:8
|
作者
Santibanez, Tammy A. [1 ]
Black, Carla L. [1 ]
Vogt, Tara M. [1 ]
Chatham-Stephens, Kevin [4 ]
Zhou, Tianyi [1 ,3 ]
Lendon, Jessica P. [2 ]
Singleton, James A. [1 ]
机构
[1] Ctr Dis Control & Prevent CDC, Natl Ctr Immunizat & Resp Dis NCIRD, 1600 Clifton Rd NE, Atlanta, GA 30329 USA
[2] Ctr Dis Control & Prevent CDC, Natl Ctr Hlth Stat NCHS, 3311 Toledo Rd, Hyattsville, MD 20782 USA
[3] Leidos Inc, 2295 Parklake Dr NE, Atlanta, GA 30345 USA
[4] Ctr Dis Control & Prevent CDC, Natl Ctr Birth Defects & Dev Disabil NCBDDD, 1600 Clifton Rd NE, Atlanta, GA 30329 USA
关键词
COVID-19; Vaccination; Vaccination setting; Children; INFLUENZA VACCINATION; MEDICAL HOME; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; COVERAGE; VACCINES;
D O I
10.1016/j.vaccine.2022.10.025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Knowing the settings where children ages 5-17 years received COVID-19 vaccination in the United States, and how settings changed over time and varied by socio-demographics, is of interest for planning and implementing vaccination programs.Methods: Data from the National Immunization Survey-Child COVID-19 Module (NIS-CCM) were ana-lyzed to assess place of COVID-19 vaccination among vaccinated children ages 5-17 years. Interviews from July 2021 thru May 2022 were included in the analyses for a total of n = 39,286 vaccinated children. The percentage of children receiving their COVID-19 vaccine at each type of setting was calculated over-all, by sociodemographic characteristics, and by month of receipt of COVID-19 vaccine.Results: Among vaccinated children ages 5-11 years, 46.9 % were vaccinated at a medical place, 37.1 % at a pharmacy, 8.1 % at a school, 4.7 % at a mass vaccination site, and 3.2 % at some other non-medical place. Among vaccinated children ages 12-17 years, 35.1 % were vaccinated at a medical place, 47.9 % at a phar-macy, 8.3 % at a mass vaccination site, 4.8 % at a school, and 4.0 % at some other non-medical place. The place varied by time among children ages 12-17 years but minimally for children ages 5-11 years. There was variability in the place of COVID-19 vaccination by age, race/ethnicity, health insurance, urbanicity, and region. Conclusion: Children ages 5-17 years predominantly received their COVID-19 vaccinations at pharmacies and medical places. The large proportion of vaccinated children receiving vaccination at pharmacies is indicative of the success in the United States of expanding the available settings where children could be vaccinated. Medical places continue to play a large role in vaccinating children, especially younger children, and should continue to stock COVID-19 vaccine to keep it available for those who are not yet vaccinated, including the newly recommended group of children < 5 years.Published by Elsevier Ltd.
引用
收藏
页码:6917 / 6923
页数:7
相关论文
共 50 条
  • [1] Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years
    Hause, Anne M.
    Shay, David K.
    Klein, Nicola P.
    Abara, Winston E.
    Baggs, James
    Cortese, Margaret M.
    Fireman, Bruce
    Gee, Julianne
    Glanz, Jason M.
    Goddard, Kristin
    Hanson, Kayla E.
    Hugueley, Brandon
    Kenigsberg, Tat'Yana
    Kharbanda, Elyse O.
    Lewin, Bruno
    Lewis, Ned
    Marquez, Paige
    Myers, Tanya
    Naleway, Allison
    Nelson, Jennifer C.
    Su, John R.
    Thompson, Deborah
    Olubajo, Babatunde
    Oster, Matthew E.
    Weintraub, Eric S.
    Williams, Joshua T. B.
    Yousaf, Anna R.
    Zerbo, Ousseny
    Zhang, Bicheng
    Shimabukuro, Tom T.
    PEDIATRICS, 2022, 150 (02)
  • [2] Factors impacting parental uptake of COVID-19 vaccination for US Children ages 5-17
    Harris, Julen N.
    Mauro, Christine M.
    Morgan, Tucker L.
    de Roche, Ariel
    Zimet, Gregory D.
    Rosenthal, Susan L.
    VACCINE, 2023, 41 (20) : 3151 - 3155
  • [3] Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study
    Ogilvie, Rachel P.
    Layton, J. Bradley
    Lloyd, Patricia C.
    Jiao, Yixin
    Djibo, Djeneba Audrey
    Wong, Hui Lee
    Gruber, Joann F.
    Parambi, Ron
    Deng, Jie
    Miller, Michael
    Song, Jennifer
    Weatherby, Lisa B.
    Peetluk, Lauren
    Lo, An-Chi
    Matuska, Kathryn
    Wernecke, Michael
    Bui, Christine L.
    Clarke, Tainya C.
    Cho, Sylvia
    Bell, Elizabeth J.
    Yang, Grace
    Amend, Kandace L.
    Forshee, Richard A.
    Anderson, Steven A.
    McMahill-Walraven, Cheryl N.
    Chillarige, Yoganand
    Anthony, Mary S.
    Seeger, John D.
    Shoaibi, Azadeh
    BMC PEDIATRICS, 2024, 24 (01)
  • [4] Social and demographic characteristics of child maltreatment fatalities among children ages 5-17 years
    Palusci, Vincent J.
    Schnitzer, Patricia G.
    Collier, Abigael
    CHILD ABUSE & NEGLECT, 2023, 136
  • [5] Characteristics of Children Ages 1-17 Who Died of COVID-19 in 2020-2022 in the United States
    Dykstra, Heather K.
    Pilkey, Diane
    Tautges, Jordan
    Schnitzer, Patricia G.
    Collier, Abigael
    Kinsman, Sara B.
    PEDIATRICS, 2024, 154
  • [6] Effectiveness of BNT162b2 COVID-19 vaccine in US children aged 5-17 years
    Ogilvie, Rachel
    Layton, J. Bradley
    Wong, Hui-Lee
    Jiao, Yixin
    Parambi, Ron J.
    Deng, Jie
    Miller, Michael
    Song, Jennifer
    Lloyd, Patricia C.
    Weatherby, Lisa
    Peetluk, Lauren S.
    Bell, Elizabeth J.
    Yang, Grace
    Amend, Kandace L.
    Kawai, Alison Tse
    Lo, An-Chi
    Matuska, Kathryn
    Wernecke, Michael
    Gruber, Joann F.
    Clarke, Tainya C.
    Forshee, Richard A.
    Anderson, Steven A.
    Anthony, Mary S.
    Chillarige, Yoganand
    Seeger, John D.
    Shoaibi, Azadeh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 78 - 79
  • [7] BNT162b2 XBB Vaccine for COVID-19 Among Children 5-17 Years of Age
    Tartof, Sara Y.
    Frankland, Timothy B.
    Puzniak, Laura
    Slezak, Jeff M.
    Ackerson, Bradley K.
    Hong, Vennis
    Stern, Julie
    Zamparo, Joann M.
    Chowdhry, Hina
    Spence, Brigitte
    Davis, Gregg S.
    Jodar, Luis
    Mclaughlin, John M.
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [8] Seroprevalence of COVID-19 antibody among children aged 5-17 years in an urban and rural area of Ernakulam District, Kerala
    Sidharthan, Saanu
    Shaik, Seenu
    Tomy, Chitra
    Mohandas, K. Sreelakshmi
    Poornima, B.
    INDIAN JOURNAL OF PUBLIC HEALTH, 2022, 66 (05) : 66 - 70
  • [9] Booster COVID-19 Vaccinations Among Persons Aged ≥5 Years and Second Booster COVID-19 Vaccinations Among Persons Aged ≥50 Years-United States, August 13, 2021-August 5, 2022
    Fast, Hannah E.
    Murthy, Bhavini Patel
    Zell, Elizabeth
    Meng, Lu
    Murthy, Neil
    Saelee, Ryan
    Lu, Peng-Jun
    Kang, Yoonjae
    Shaw, Lauren
    Gibbs-Scharf, Lynn
    Harris, LaTreace
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (35): : 1121 - 1125
  • [10] Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study
    Shi, Ting
    Pan, Jiafeng
    Katikireddi, Srinivasa Vittal
    McCowan, Colin
    Kerr, Steven
    Agrawal, Utkarsh
    Shah, Syed Ahmar
    Simpson, Colin R.
    Ritchie, Lewis Duthie
    Robertson, Chris
    Sheikh, Aziz
    LANCET RESPIRATORY MEDICINE, 2022, 10 (02): : 191 - 198